Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (252)

2023

  1. Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies

    Journal of the American Heart Association, Vol. 12, Núm. 12, pp. e027657

  2. Best practices for applying the Nova food classification system

    Nature Food

  3. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 2, pp. 328-343

  4. Epimutation detection in the clinical context: guidelines and a use case from a new Bioconductor package

    Zenodo

  5. Epimutation detection in the clinical context: guidelines and a use case from a new Bioconductor package

    Zenodo

  6. Exploring Uncertainty for Clinical Acceptability in Head and Neck Deep Learning-Based OAR Segmentation

    Proceedings - International Symposium on Biomedical Imaging

  7. Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study

    JHEP Reports, Vol. 5, Núm. 2

  8. Highlight selection of radiochemistry and radiopharmacy developments by editorial board

    EJNMMI Radiopharmacy and Chemistry, Vol. 8, Núm. 1

  9. Microsecretory adenocarcinoma of the skin, a novel type of sweat gland carcinoma: Report of three additional cases

    Journal of Cutaneous Pathology, Vol. 50, Núm. 10, pp. 897-902

  10. Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study

    CardioVascular and Interventional Radiology, Vol. 46, Núm. 7, pp. 852-867

  11. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  12. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 47

  13. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 47